Ninety One’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
27,313
-5,421
-17% -$2.6M 0.74% 22
2026
Q1
$16M Buy
32,734
+4,542
+16% +$2.46M 0.69% 18
2025
Q4
$16.3M Buy
28,192
+1,137
+4% +$643K 0.71% 21
2025
Q3
$12.9M Buy
27,055
+12,522
+86% +$5.83M 0.58% 30
2025
Q2
$5.9M Sell
14,533
-39
-0.3% -$16.3K 0.97% 31
2025
Q1
$7.25M Sell
14,572
-350
-2% -$190K 1.34% 23
2024
Q4
$7.76M Buy
14,922
+653
+5% +$359K 1.71% 17
2024
Q3
$8.82M Sell
14,269
-6,300
-31% -$3.73M 1.93% 15
2024
Q2
$11.4M Sell
20,569
-2,327
-10% -$1.33M 1.77% 17
2024
Q1
$13.3M Buy
22,896
+1,713
+8% +$961K 1.91% 14
2023
Q4
$11.2M Buy
21,183
+1,179
+6% +$571K 1.71% 20
2023
Q3
$10.1M Buy
20,004
+7,245
+57% +$3.86M 1.96% 17
2023
Q2
$6.62M Buy
12,759
+753
+6% +$406K 1.64% 18
2023
Q1
$6.87M Sell
12,006
-103
-0.9% -$58.1K 1.75% 17
2022
Q4
$6.65M Buy
12,109
+685
+6% +$363K 2.16% 14
2022
Q3
$5.93M Buy
11,424
+3,876
+51% +$2.17M 2.35% 13
2022
Q2
$4.03M Buy
7,548
+1,840
+32% +$1.01M 1.43% 16
2022
Q1
$3.42M Hold
5,708
0.96% 24
2021
Q4
$3.81M Buy
5,708
+542
+10% +$338K 1.11% 24
2021
Q3
$3.02M Sell
5,166
-57
-1% -$31.3K 1.17% 22
2021
Q2
$2.64M Sell
5,223
-511
-9% -$241K 0.97% 23
2021
Q1
$2.62M Sell
5,734
-1,546
-21% -$738K 0.99% 21
2020
Q4
$3.36M Buy
7,280
+2,150
+42% +$1.01M 1.32% 18
2020
Q3
$2.25M Buy
5,130
+81
+2% +$33.5K 1.14% 25
2020
Q2
$1.8M Buy
5,049
+33
+0.7% +$11.1K 0.86% 28
2020
Q1
$1.41M Sell
5,016
-3,221
-39% -$1.02M 0.69% 35
2019
Q4
$2.4M Hold
8,237
1.35% 20
2019
Q3
$2.4M Sell
8,237
-217
-3% -$62.1K 1.35% 20
2019
Q2
$2.45M Buy
8,454
+930
+12% +$256K 1.37% 20
2019
Q1
$2.04M Buy
7,524
+196
+3% +$48.8K 1.08% 23
2018
Q4
$1.65M Sell
7,328
-17,594
-71% -$4.13M 0.97% 26
2018
Q3
$6.09M Sell
24,922
-9,889
-28% -$2.27M 1% 24
2018
Q2
$7.22M Buy
34,811
+28,074
+417% +$5.96M 0.98% 26
2018
Q1
$1.39M Sell
6,737
-6,784
-50% -$1.42M 0.65% 36
2017
Q4
$2.58M Hold
13,521
1.29% 15
2017
Q3
$2.54M Buy
13,521
+443
+3% +$80.2K 1.34% 14
2017
Q2
$2.29M Buy
13,078
+4,443
+51% +$746K 1.27% 13
2017
Q1
$1.33M Buy
8,635
+263
+3% +$40.2K 0.87% 16
2016
Q4
$1.18M Hold
8,372
0.8% 18
2016
Q3
$1.32M Buy
+8,372
New +$1.29M 0.84% 19

Other funds holding TMO

Ninety One's TMO Position: Q2 2026 in Review

Ninety One reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q2 2026, selling an estimated $2.6M and leaving 27,313 shares worth $13.7M. The position accounts for 0.74% of the portfolio, ranked #22.

Ninety One first reported a position in TMO in Q3 2016 and has held it in 40 quarters since. The position peaked at $16.3M in Q4 2025. 1,164 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ninety One held 27,313 shares of Thermo Fisher Scientific worth $13.7M as of Q2 2026.
  • Ninety One sold 5,421 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.6M.
  • Thermo Fisher Scientific made up 0.74% of Ninety One's portfolio in Q2 2026, its #22 holding.
  • Ninety One first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 40 quarters since.
  • Ninety One's Thermo Fisher Scientific position peaked at $16.3M in Q4 2025.
  • 1,164 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ninety One's 13F filing for Q2 2026, filed 16 Jul 2026.